
Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from nanopore sequencing
Here Katsman et al. show that cell-free DNA can be used to detect cell-type specific and cancer-specific methylation changes, as well as cancer-associated fragmentation signatures, using shallow Oxford Nanopore whole-genome sequencing (WGS) of liquid biopsies. Discussing the platform’s potential, they state that ‘the simplicity of native [nanopore] sequencing and the number of features that can be extracted from a single run, combined with the low cost and portability of [the] sequencer, make it an interesting proposition for clinical settings’.
Read more
De novo assembly of human genome at single-cell levels
Read more
Metagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections
Read moreCommunity News
In the Nanopore Community, customers raise discussions to connect with others working on the same things, or give guidance to other users. Current discussions include:
- RNA direct sequencing-Structure variant
- Kit for metagenomic CSF sample
- Short read lengths from plasmid sequencing
- PCR Barcoding Amplicons
Get started to join the community today.

Knowledge Exchange: Methylation detection with nanopore sequencing: Reduced-Representation Methylation Sequencing
This Knowledge Exchange, taking place on 16th August at 3 pm (BST), will introduce Reduced-Representation Methylation Sequencing (RRMS): a targeted methylation detection method utilising adaptive sampling for cost-effective, PCR-free enrichment during sequencing. With RRMS you can uncover changes in methylation patterns associated with changes in gene expression and diseases such as cancer, as well as call CNVs, without any additional sample prep.
Read more
Cancer Research Symposium APAC
The mechanisms driving cancer are both diverse and complex. This symposium will bring together experts in cancer research, where they’ll cover how they are using nanopore sequencing to achieve the most comprehensive insight into cancer genomes.
Read more